n(4)-hydroxycytidine has been researched along with azauridine in 1 studies
Studies (n(4)-hydroxycytidine) | Trials (n(4)-hydroxycytidine) | Recent Studies (post-2010) (n(4)-hydroxycytidine) | Studies (azauridine) | Trials (azauridine) | Recent Studies (post-2010) (azauridine) |
---|---|---|---|---|---|
42 | 1 | 32 | 309 | 7 | 29 |
Protein | Taxonomy | n(4)-hydroxycytidine (IC50) | azauridine (IC50) |
---|---|---|---|
Janus kinase 2 (a protein tyrosine kinase) | Homo sapiens (human) | 6.798 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkhout, B; Bosch, BJ; Dijkman, R; Jebbink, MF; Pyrc, K; Rottier, P; van der Hoek, L | 1 |
1 other study(ies) available for n(4)-hydroxycytidine and azauridine
Article | Year |
---|---|
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
Topics: Animals; Antiviral Agents; Azauridine; Base Sequence; Cell Line; Cell Survival; Coronavirus; Coronavirus Infections; Cytidine; Cytopathogenic Effect, Viral; Humans; Inhibitory Concentration 50; Macaca mulatta; Molecular Structure; Neutralization Tests; Nucleosides; Receptors, Virus; RNA Interference; RNA, Small Interfering; RNA, Viral; Time Factors; Virus Replication | 2006 |